Vertex Pharmaceuticals Incorporated (VRTX) Short Interest
Nasdaq • VRTX • US92532F1003
As of Nov 3, 2026, ORTEX estimates 1.8% of free float is sold short, 2.8 days to cover, cost to borrow 0.48%.
Nasdaq • VRTX • US92532F1003
As of Nov 3, 2026, ORTEX estimates 1.8% of free float is sold short, 2.8 days to cover, cost to borrow 0.48%.
This page tracks how heavily Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has a market capitalization of $139.2B. Last close $549.04 (as of 2026-11-05); 52-week range $406.67 to $568.67. ORTEX data as of 2026-11-03: short interest is 1.76% of free float, 2.8 days to cover and the average cost to borrow is 0.48%.